학술논문
P-173: Impact of Daratumumab (DARA) administration during transplant-eligible newly diagnosed Multiple Myeloma (TE NDMM) induction on stem cell (SC) mobilization count and post-transplant engraftment
Document Type
Abstract
Author
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2021 21 Supplement 2:S131-S131
Subject
Language
ISSN
2152-2650